Advertisement

Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 600x60px
Document › Details

ImaBiotech S.A.S.. (11/10/15). "Press Release: Galderma and ImaBiotech Develop a Long-term Alliance to Access Multimaging Services". Lille & Sophia Antipolis.

Organisations Organisation ImaBiotech S.A.S.
  Group ImaBiotech (Group)
  Organisation 2 Galderma R&D SNC
  Group Nestlé (Group)
Product Product Multimaging™ technology (combined Mass Spectrometry Imaging and Immuno-histology, ImaBiotech)
Index term Index term Nestlé–ImaBiotech: mass spectrometry services, 201511– supply Multimaging services for Galderma’s drug development
Person Person Stauber, Jonathan (ImaBiotech 201206 CEO)
     


Galderma a leading pharmaceutical company in Dermatology has chosen ImaBiotech to support their drug development with innovative Multimaging™ services.

Galderma has chosen ImaBiotech’s Multimaging™ services to combine and accelerate its drug pharmacokinetic, pharmacology, toxicology and formulation phases. Multimaging™ is a combination of imaging techniques (Quantitative MALDI imaging, staining, immune-staining) associated with dedicated software. This platform has the capability to jointly study quantitatively the distribution of analytes at a cellular level. It can be used during drug discovery and development, resulting in a better and faster drug selection for clinical phase.

Galderma is interested in the capabilities of ImaBiotech’s MALDI imaging platform and would benefit from the Multimaging™ services to support their drug investigations. ImaBiotech will provide analysis of Galderma samples to investigate drug, metabolites and biomarker distribution quickly and efficiently.

Dr Laurent Hennequin, Director of Research and Dr Philippe Andres, Director of Global Evaluation, Galderma R&D “We consider ImaBiotech as a key partner to help us to visualise our compounds in skin through imaging. Knowing the challenge which is the quantification and the localization of analytes, including biomarkers, in skin, we consider that ImaBiotech technologies can lead us quicker to better and safer products.”

Dr Jonathan Stauber, CEO of ImaBiotech adds ”We are more than proud to become a partner of Galderma, world-known as a major pharmaceutical company. This new partnership is a proof that our company and its Multimaging™ technology have become key players in the Molecular imaging field in less than a year.”


Contact: ImaBiotech
Jonathan Stauber, PhD, ImaBiotech
Chief Executive Officer
E: contact@imabiotech.com
T: +33 (0) 320 164 091

Contact: Galderma
Philippe Andres, Galderma R&D
Director of Global Evaluation
E: philippe.andres@galderma.com
T: +33 (0) 492 952 997

   
Record changed: 2016-05-01

Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px

More documents for ImaBiotech (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture BIO Deutschland EBDC 2017 Heidelberg 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px